Introduction
Patients in the more advanced stages of human immunodeficiency virus (H IV)-l infection may develop a particular pattern of motor slowing, cognitive disturbances and minor neurological signs. The decline of cognitive functions is one of the main sou rces of morbidity in HIV-l infection because patients became disabled in their social function s and therefo re should be diagnosed as being demented according to the widely used Diagnos tic and Statistical Manual of M ental Disorders published by the American Psychiatric Association (1) .
The so-called AIDS Demen tia Complex (ADC) was observed as initial clinical ma nifestation of HIV-l infection rarely detected even in patients wit h minor immunological abnormalities and preceding the occurrence of opportunistic infections (2, 3) . Its pathogenesis still rema ins to be elucidated. Specific humoral antibodies against HIV-1 in cerebrospinal fluid (CSF) were detected in abo ut 70% even totally asymptomatic patients in the first stages of infection (4), but there is no con vinci ng correlation of neuropsyc hiatric symptoms and specific antibodies in CSF (5) . The prese nce of viral antigen has been demonstrated in macrophages a nd microgli a l cells. Nevertheless, the ne uronal population is not or on ly rarel y affected (6) . Infection of astrocytes cultures has shown no expression of viral transcripts and no signs of cytopa thology.
Because of the wide spectrum of HIV-l-associated diseases and the often nonspecific neuropa thological changes seen in post mortem exa mination of the brain , speculation on possible mechanism of neurological
Cop yright (c) 1991 Wa lter de Gru yter . Berlin' New Yo rk disease has been rife. It has been assumed that cerebral HIV -1 infection may interfere with neuronal tran smi ssio n. Tryptophan was fo und to be decreased in sera and CSF of HIV-l-infected patients , but the clinical relevance of this finding remains controversial (7) .
HIV -1 infecti o n causes a chronic immune respon se . Some autoimmune diseases arc observed with higher frequency in HIV-\ infec tion (8) . Neopterin was found to be increased in sera of patients with chronic infla mmatory and autoimmune di seases (9) . Large amounts of neopterin are released by human mon ocytes when they become stimulated by gamma interferon. Gamma interferon a lso stimulates macrophages to degrade tryptophan, closely correlated with the production of kynurenine and neopterin. We were interested to investigate a possible association between disturbed tryptophan metabolism , chronic immune stimulation and neuropsychiatric symptomatology in HTV -I-infected pa tients .
Material and Methods
We investigated neopterin , kynurenine a nd tryptophan by HPLC assay (9) in se ra of 34 and CSF of 24 patients in different stages of HIV-l infection (age range 22 -55 yr) . The stage of infection was defined by using the Walter Reed Staging Class ification (WR) which integrates clinical and immunological data (10) . All patients were neurologically examined, underwent cranial computerized tomography and were interviewed by using a structured interview (SIDAM) whose diagnostic algorithm is based on the DSM-III-R criteria of dementia (1, 11) . Patients can achieve a score of 55 as the best possible result whereas those with dementive illness usually would show poorer performance with scores below 40 (11) . Those patients with symptoms of cerebral opportunistic infections or neoplasms (focal neurological deficits or circumscribed lesions of the brain seen in cranial computerized tomography) were excluded.
Correlation analysis was done by using the Spearman rank correlation.
Results
Levels of serum neopterin, tryptophan, and the kynurenine/ tryptophan ratio in sera showed significant changes in comparison of different WR stages (Table  1) . Neopterin increases to significant higher levels in the course of HIV-1 infection showing the highest concentration in A IDS (W R 6) (p < 0.01). Tryptophan showed a significant decline in the course of HIV -1 infection and was found to be negatively correlated to neopterin concentrations (r = -0.70, p < 0.01). The ratio of kynurenine and tryptophan increases significantly (p < 0.05).
In CSF analyses, patients showed the same tendency. However, comparing patients in WR 6 to those in WR 5 the differences did not reach the level of statistical significance (Table 1) . I n analysis of psychopathometrie results, we were unable to confirm an obvious relationship to all stages of the WR classification system. Only AIDS patients (WR 6) showed lesser scores of the SIDAM in comparison to all preceding stages (WR 2 -5), whereas no differences could be demonstrated between other subgroups (data not shown). Significant associations between the performance in psychiatric interview (SI-DAM score) and concentrations of neopterin and tryptophan were found ( Table 2) .
Discussion
Previous reports on increased levels of neopterin and decreased concentrations of tryptophan were confirmed by our results. HIV -1 infection causes a chronic immune stimulation and autoimmune phenomena are known to occur more often in its clinical course than in the normal population (8) . As an impact of this immune activation elevated levels of ncopterin were demonstrated, which is produced by human macrophages stimulated by interferon gamma. Interferon was also reported to be increased in sera of HIV -1 infected individuals (12) .
Tryptophan and neopterin in sera were negatively correlated. This finding may indicate that immune activation is involved in disturbed tryptophan metabolism. In vitro data have shown that neopterin release is paralleled by the induction of indoleamine (2,3)-dioxygenase (IDO) which degrades tryptophan to kynurenine (13) . In our samples a positive correlation existed between kynurenine and neopterin levels in sera and CSF (r = 0.39, p < 0.05 in sera; r = 0.58, p < 0.01 in CSF), which supports the concept that chronic immune stimulation and increased degradation of tryptophan may be the reason for reduced tryptophan levels rather than reduced dietary intake. Activation of 100 can be estimated by the ratio of the product concentration (kynurenine) versus the substrate concentration (tryptophan). A significant positive correlation between this ratio and neopterin in sera (r = 0.88, p < 0.01; r = 0.35, p = 0.09 in CSF)
indicates that both events. neopterin release and degradation of tryptophan can be referred to the activity of cytokines.
We conclude that the chronic release of cytokines in HIV-l infection may cause changes in neurotransmitter metabolism as indicated by decrease of tryptophan. the precursor of 5-hydroxytryptamin (serotonin), and may contribute to the neuropsychiatric symptomatology of infected individuals.
